Everwell Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-07-2024
- Paid Up Capital ₹ 5.00 M
as on 17-07-2024
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.62 Cr
as on 17-07-2024
- Satisfied Charges ₹ 1.00 M
as on 17-07-2024
- Revenue -10.75%
(FY 2023)
- Profit -8.09%
(FY 2023)
- Ebitda 5.35%
(FY 2023)
- Net Worth 316.39%
(FY 2023)
- Total Assets 62.39%
(FY 2023)
About Everwell Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.62 Cr. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Chander Mohan and Manish Bhalla serve as directors at the Company.
- CIN/LLPIN
U51900CH2014PTC035248
- Company No.
035248
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Oct 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Everwell Pharma Private Limited offer?
Everwell Pharma Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pharma & Bioanalytical Services, PCD Pharma Franchise, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Respiratory System Drugs, Anti Asthma Drug, Common Disease Medicines, Ointment.
Who are the key members and board of directors at Everwell Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chander Mohan  | Director | 17-Oct-2014 | Current |
| Manish Bhalla | Director | 17-Oct-2014 | Current |
Financial Performance of Everwell Pharma.
Everwell Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.75% decrease. The company also saw a slight decrease in profitability, with a 8.09% decrease in profit. The company's net worth Soared by an impressive increase of 316.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Everwell Pharma?
In 2023, Everwell Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 16 Nov 2022 | ₹1.50 Cr | Open |
Canara Bank Creation Date: 10 Jul 2020 | ₹1.24 M | Open |
Central Bank Of India Creation Date: 04 Feb 2015 | ₹1.00 M | Satisfied |
How Many Employees Work at Everwell Pharma?
Unlock and access historical data on people associated with Everwell Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Everwell Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Everwell Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
